Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK3858279 in Healthy Caucasian, Chinese and Japanese Participants
Clinical trial NCT05174013 · COMPLETED
Trial details
- NCT number
- NCT05174013
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-14
- Primary completion
- 2023-02-10
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.